|
RANBP2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.34369959603475E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.29261054585095E-13 |
| Normal-vs-Stage2 |
4.50030000043178E-07 |
| Normal-vs-Stage3 |
4.32239799508238E-11 |
| Normal-vs-Stage4 |
2.36344277482203E-12 |
| Stage1-vs-Stage2 |
9.364200E-01 |
| Stage1-vs-Stage3 |
1.242650E-01 |
| Stage1-vs-Stage4 |
2.140000E-03 |
| Stage2-vs-Stage3 |
2.582800E-01 |
| Stage2-vs-Stage4 |
3.959600E-02 |
| Stage3-vs-Stage4 |
1.518380E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.23320020861684E-10 |
| Normal-vs-AfricanAmerican |
3.042600E-04 |
| Normal-vs-Asian |
1.23550003561235E-09 |
| Caucasian-vs-AfricanAmerican |
2.375400E-01 |
| Caucasian-vs-Asian |
5.999600E-01 |
| AfricanAmerican-vs-Asian |
1.661820E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.03279640184928E-11 |
| Normal-vs-Female |
1.62903024403249E-12 |
| Male-vs-Female |
2.821800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.43089984305789E-11 |
| Normal-vs-Age(41-60Yrs) |
5.99520433297585E-15 |
| Normal-vs-Age(61-80Yrs) |
1.80049974929375E-10 |
| Normal-vs-Age(81-100Yrs) |
6.717700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.094000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.611800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.724600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.458000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.124400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.892000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.104600E-03 |
| Classical-VS-Follicular |
2.352200E-01 |
| Classical-VS-Other |
1.253240E-01 |
| Classical-VS-Normal |
4.67899996525745E-09 |
| Tall-VS-Follicular |
1.204610E-01 |
| Tall-VS-Other |
6.793600E-01 |
| Tall-VS-Normal |
3.52320395080596E-11 |
| Follicular-VS-Other |
3.230400E-01 |
| Follicular-VS-Normal |
3.14339998475077E-10 |
| Other-VS-Normal |
3.379900E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.86517468137026E-14 |
| Normal-vs-N1 |
1.08799635967216E-11 |
| N0-vs-N1 |
9.576100E-02 |
|
|
